Skip to main content

UBS Group AG

Position in CLYM — Climb Bio, Inc.

CIK 1610520 ZURICH, V8

Position in CLYM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$44,399,452
+$43,810,729 QoQ
Shares Held
3,404,866
+3861.7% QoQ
Ownership
5.93%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 108 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLYM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. CLYM ranks #39 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLYM

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,399,452 3,404,866
2026-03-31 $588,723 85,945
2025-12-31 $285,292 71,323
2025-09-30 $814,862 405,404
2025-06-30 $474,277 382,482
2025-03-31 $466,314 382,225
2024-12-31 $747,638 415,355
2024-09-30 $82,697 16,247
2024-06-30 $15,769 2,218
2024-03-31 $16,234 5,925
2023-09-30 $234 89
2022-06-30 $6,891 2,282
2022-03-31 $13,558 1,616
2021-12-31 $46,421 4,438
2021-09-30 $249,436 13,873